Tiziana Life Sciences (LON:TILS)

Tiziana Life Sciences (LON:TILS)


Share Price
57.50 p
Change
-2.5 (-4.17 %)
Market Cap
£78.47 m
Proactive Investors - Run By Investors For Investors

Tiziana Life Sciences

Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biotechnology company that specializes in the developing transformative therapies for inflammatory diseases and cancer related to the liver. Our clinical pipeline includes drug assets for NASH, Crohn's, and hepatocellular carcinoma. Tiziana is led by a team of highly qualified executives with extensive drug...

EPIC: TILS
Market: AIM:TILS
52-week High/Low: 148.000p / 36.000p
Sector: Pharma & Biotech
Market Cap: £78.47 m
Website: www.tizianalifesciences.com
col 3
col 4
col 5
col 6

Tiziana Life Sciences Timeline

RNS
July 01 2019
RNS
June 29 2019
RNS
June 29 2019
RNS
June 28 2019
RNS
June 25 2019
RNS
June 11 2019
RNS
June 07 2019
RNS
June 03 2019
RNS
May 31 2019

Columns Including TILS

VIEW ALL

Market Reports Including TILS

VIEW ALL
Video RSS

Videos

VIEW ALL VIDEOS

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use